Attached files

file filename
8-K/A - RAYONT INC.form8-ka.htm
EX-99.2 - RAYONT INC.ex99-2.htm
EX-99.1 - RAYONT INC.ex99-1.htm

 

EXHIBIT 99.3

RAYONT INC.

UNAUDITED PRO FORMA CONDENSED COMBINED BALANCE SHEET

AS OF DECEMBER 31, 2020

(Currency expressed in United States Dollars (“US$”))

(Unaudited)

 

  

Rayont Group

#

   Prema Life   GGLG   Total   Pro Forma
Adjustments
(Note 3)
   Pro Forma
Combined
 
   USD   USD   USD   USD   USD   USD 
ASSETS                              
CURRENT ASSETS                              
Cash and bank balances  $39,255   $108,590   $2,134   $149,979        $149,979 
Amount due from related parties   545,061    293,815    -    838,876    (823,996)   14,880 
Other receivables, deposits and prepayments   96,112    -    -    96,112         96,112 
Trade receivables   75,093    166,606    4,268    245,967         245,967 
Inventories   -    490,183    -    490,183         490,183 
Total current assets   755,521    1,059,194    6,402    1,821,117    (823,996)   997,121 
                               
NON-CURRENT ASSETS                              
Plant and equipment, net   893,516    -    642,726    1,536,242         1,536,242 
Intangible assets   2,466,157    -    -    2,466,157         2,466,157 
Total non-current assets   3,359,673    -    642,726    4,002,399         4,002,399 
TOTAL ASSETS  $4,115,194   $1,059,194   $649,128   $5,823,516    (823,996)  $4,999,520 
                               
LIABILITIES AND STOCKHOLDERS’ EQUITY                              
CURRENT LIABILITIES                              
Trade payables  $-   $107,652   $-   $107,652        $107,652 
Amount due to related parties   5,190    -    25,560    30,750    580,360    611,110 
Other payables and accrued liabilities   313,367    166,180    9,781    489,328         489,328 
Loan payable   268,275    -    508,760    777,035    (268,255)   508,780 
Finance lease   -    -    8,076    8,076         8,076 
Total current liabilities   586,832    273,832    552,177    1,412,841    312,105    1,724,946 
                               
NON-CURRENT LIABILITIES                              
Finance lease   -    -    24,696    24,696         24,696 
Loan payable   -    192,712    -    192,712         192,712 
Total non-current liabilities   -    192,712    24,696    217,408         217,408 
TOTAL LIABILITIES  $586,832   $466,544   $576,873   $1,630,249    312,105   $1,942,354 
                               
STOCKHOLDERS’ EQUITY                              
Stockholders’ equity  $46,695   $1,410,998   $791,745   $2,249,438    (2,202,743)  $46,695 
Additional paid-in capital   7,249,626    -    -    7,249,626    (471,196)   6,778,430 
Stock subscription receivables   (72,774)   -    -    (72,774)   -    (72,774)
Capital loss reserve   -    -    (397,108)   (397,108)   397,108    - 
Accumulated losses   (3,686,465)   (823,043)   (310,091)   (4,819,599)   1,133,134    (3,686,465)
Other comprehensive income/(losses)   (8,720)   4,695    (12,291)   (16,316)   7,596    (8,720)
TOTAL STOCKHOLDERS’ EQUITY   3,528,362    592,650    72,255    4,193,267    (1,136,101)   3,057,166 
                               
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY  $4,115,194   $1,059,194   $649,128   $5,823,516    (823,996)  $4,999,520 

 

See accompanying notes to unaudited pro forma condensed combined financial statements

 

1
 

 

RAYONT INC.

UNAUDITED PRO FORMA CONDENSED COMBINED STATEMENT OF OPERATIONS

FOR THE YEAR ENDED SEPTEMBER 30, 2020

(Currency expressed in United States Dollars (“US$”))

(Unaudited)

 

   Rayont Group #   Prema Life   GGLG      Pro Forma    
   September 30, 2020   June 30, 2020   June 30, 2020   Total   Adjustments (Note 3)   Pro Forma Combined 
   USD   USD   USD   USD   USD   USD 
REVENUE  $           186,663   $1,574,148   $53,799   $1,814,610   $(45,403)  $1,769,206 
COST OF REVENUE   -    (894,182)   -    (894,182)   -    (894,182)
GROSS PROFIT   186,663    679,966    53,799    920,428    (45,403)   875,025 
                               
OTHER INCOME   13,537    572,631    -    586,168         586,168 
OPERATING EXPENSES   (425,525)   (1,283,773)   (88,231)   (1,797,529)   45,403    (1,752,126)
 LOSS FROM OPERATIONS   (225,325)   (31,176)   (34,432)   (290,933)   -    (290,933)
                               
FINANCE COSTS   (4,120)   (10,617)   (29,207)   (43,944)   -    (43,944)
                               
NET LOSS  $(229,445)  $(41,793)  $(63,639)  $(334,877)  $-   $(334,877)
                               
OTHER COMPREHENSIVE GAIN/(LOSS)                              
Foreign currency translation gain/(loss)   36,354    (3,757)   (4,930)   27,667    -    27,667 
                               
TOTAL COMPREHENSIVE LOSS  $(193,091)  $(45,550)  $(68,569)  $(307,210)  $-   $(307,210)
                               
Basic and diluted loss per share of common stock   (0.006)                       (0.008)
Weighted average number of shares of common stock outstanding   40,828,756                        40,828,756 

 

# Prior to acquisition of Prema Life and GGLG

 

See accompanying notes to unaudited pro forma condensed combined financial statements

 

2
 

 

RAYONT INC.

UNAUDITED PRO FORMA CONDENSED COMBINED STATEMENT OF OPERATIONS

THREE MONTHS PERIOD ENDED DECEMBER 31, 2020

(Currency expressed in United States Dollars (“US$”))

(Unaudited)

 

   Rayont Group #   Prema Life   GGLG   Total   Pro Forma
Adjustments
(Note 4)
   Pro Forma
Combined
 
   USD   USD   USD   USD   USD   USD 
REVENUE  $43,354   $414,650   $18,537   $476,541   $(18,537)  $458,004 
COST OF REVENUE   (13,105)   (263,480)   -    (276,585)   -    (276,585)
GROSS PROFIT   30,249    151,170    18,537    199,956    (18,537)   181,419 
                               
OTHER INCOME   259,294    231,591    -    490,885    -    490,885 
OPERATING EXPENSES   (275,299)   (250,434)   (24,898)   (550,631)   18,537    (532,094)
                               
PROFIT/(LOSS) FROM OPERATIONS   14,244    132,327    (6,361)   140,210         140,210 
                               
FINANCE COSTS   -    -    (12,333)   (12,333)   -    (12,333)
                               
NET PROFIT/(LOSS)  $14,244   $132,327   $(18,694)  $127,877   $-   $127,877 
                               
OTHER COMPREHENSIVE GAIN                              
Foreign currency translation gain   31,734    22,964    5,828    60,526    -    60,526 
                               
TOTAL COMPREHENSIVE INCOME/(LOSS)  $45,978   $155,291   $(12,866)  $188,403   $-   $188,403 
                               
Basic and diluted income per share of common stock   0.0003                    0.0031 
Weighted average number of shares of common stock outstanding   40,828,756                    40,828,756 

 

 

# Prior to acquisition of Prema Life and GGLG

 

See accompanying notes to unaudited pro forma condensed combined financial statements

 

3
 

 

 

RAYONT INC.

NOTES TO UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL STATEMENTS

(Currency expressed in United States Dollars (“US$”))

(Unaudited)

 

The following unaudited pro forma condensed combined financial statements are based on the historical financial statements of Rayont Inc. (“Rayont”), Prema Life Pty. Ltd. (“Prema Life”) and GGLG Properties Pty. Ltd. (“GGLG”) after giving effect to Rayont’s acquisition of Prema Life and GGLG (“the Acquisitions”) and the assumptions and adjustments described in the accompanying notes to the unaudited pro forma condensed combined financial statements.

 

Note 1. Basis of Pro Forma Presentation

 

The unaudited pro forma condensed combined financial statements are not intended to represent or be indicative of the results of operations or financial position of Rayont that would have been reported had the Acquisition been completed as of the dates presented, and should not be taken as representative of the future results of operations or financial position of Rayont. The unaudited pro forma financial statements, including the notes thereto, do not reflect any potential operating efficiencies and cost savings that Rayont may achieve with respect to the combined companies. The unaudited pro forma condensed combined financial statements and notes thereto should be read in conjunction with the historical financial statements of Rayont included in the annual report on Form 10-K for the year ended September 30, 2020 had been filed with the Securities and Exchange Commission (the “SEC”) on December 18, 2020 and the subsequent quarterly report on Form 10-Q for the three months ended December 31, 2020 filed with the SEC on February 16, 2021, and in conjunction with the historical financial statements of Prema Life and GGLG included in this Form 8-K.

 

The unaudited pro forma condensed combined balance sheet as of December 31, 2020 is presented as if the Acquisition occurred on December 31, 2020.

 

The unaudited pro forma condensed combined statement of operations and comprehensive income/(loss) of the Rayont and Prema Life and GGLG for the year ended September 30, 2020 has been prepared by combining the Rayont’s historical consolidated results for the year ended September 30, 2020 and the historical results of Prema Life and GGLG for the year ended June 30, 2020.

 

The unaudited pro forma combined statement of operations and comprehensive loss for the 3 months period ended December 31, 2020 has been prepared by combining the Company’s historical consolidated results for the period ended from October 1, 2020 to December 31, 2020, with the historical results of Prema Life and GGLG for the period ended from October 1, 2020 to December 31, 2020.

 

Note 2. Prema Life and GGLG Acquisition

 

On December 23, 2020, pursuant to an Acquisition Agreement, Rayont Australia Pty Ltd, a wholly-owned subsidiary of Rayont Inc., acquired all of the issued and outstanding capital stock of Prema Life, an Australian company, from TheAlikasa (Australia) Pty Ltd, Prema Life’s sole shareholder (the “Seller”). The Seller is an affiliate of the Rayont and therefore the acquisition is being treated as a related party transaction. The purchase price is $530,180, which is a 10% discount of the total amount of Prema Life’s net tangible assets. The purchase price will be paid in six installments after a $265,300 down payment. In the event an installment payment is not paid timely, the Seller has agreed to accept shares of the Company valued at $0.87 per share. The price per share is based on a 20% discount of the average share price on the OTC Markets over the last 30 trading days.

 

On December 23, 2020, pursuant to an Acquisition Agreement, Rayont Australia Pty Ltd, a wholly-owned subsidiary of Rayont Inc., acquired all of the issued and outstanding capital stock of GGLG, an Australian company, from TheAlikasa (Australia) Pty Ltd, GGLG’s sole shareholder. The Seller is an affiliate of the Company and therefore the acquisition is being treated as a related party transaction. The purchase price is $605,920, which is a 10% discount of the total amount of GGLG’s net tangible assets. The purchase price will be paid in six installments after a $265,300 down payment. In the event an installment payment is not paid timely, the Seller has agreed to accept shares of the Company valued at $0.87 per share. The price per share is based on a 20% discount of the average share price on the OTC Markets over the last 30 trading days.

 

4
 

 

The acquisitions of Prema Life and GGLG have been accounted for as a common control transaction as there is no change in the control over the assets acquired and liabilities assumed. The net assets are derecognized by the transferring entity (i.e. Rayont) and recognized by the receiving entity (i.e. Prema Life and GGLG). The difference between the consideration transferred and the carrying amounts of the net assets is recognized in additional paid-in capital.

 

The acquisitions of Prema Life and GGLG were completed on December 23, 2020 and February 22, 2021 respectively.

 

Note 3. Pro Forma Adjustments

 

The following pro forma adjustments are included in the unaudited pro forma condensed combined balance sheet and combined statement of operations for the year ended September 30, 2020:

 

(A) To record the following adjustments to amount due from related parties:

 

Balance before pro forma adjustments  $838,876 
Effects of intercompany eliminations – Prema Life and GGLG   (823,996)
Pro Forma Combined as of September 30, 2020  $14,880 

 

The remaining amount of $14,880 represents amount due from Rural Asset Management Services, Inc. and Blue Pacific Academy Inc..

 

(B) To record the following adjustments to amount due to related parties:

 

Balance before pro forma adjustments  $30,750 
Effects of intercompany eliminations – GGLG   (25,560)
Effects of acquisition of GGLG – Consideration paid in six months instalment   605,920 
Pro Forma Combined as of September 30, 2020  $611,110 

 

(C) To record the following adjustments to loan payable:

 

Balance before pro forma adjustments  $777,035 
Effects of intercompany eliminations – Prema Life and GGLG   (268,255)
Pro Forma Combined as of September 30, 2020  $508,780 

 

(D) To record the following adjustments to shareholders’ equity:

 

  i) Adjustments to stockholders’ equity

 

Balance before pro forma adjustments  $2,249,438 
Elimination of pre-acquisition equity account of - Prema Life   (1,410,998)
Elimination of pre-acquisition equity account of - GGLG   (791,745)
Pro Forma Combined as of September 30, 2020  $46,695 

 

  ii) To record the following adjustments to additional paid-in capital:

 

Balance before pro forma adjustments  $7,249,626 
Elimination of pre-acquisition equity account of - Prema Life   62,470 
Elimination of pre-acquisition equity account of - GGLG   (533,666)
Pro Forma Combined as of September 30, 2020  $6,778,430 

 

5
 

 

RAYONT INC.

NOTES TO UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL STATEMENTS

 

(Currency expressed in United States Dollars (“US$”))

(Unaudited)

  iii) To record the following adjustments to capital loss reserve:

 

Balance before pro forma adjustments  $(397,108)
Elimination of pre-acquisition equity account of GGLG   397,108 
Pro Forma Combined as of September 30, 2020  $- 

 

  iv) To record the following adjustments to accumulated losses:

 

Balance before pro forma adjustments  $(4,819,599)
Elimination of pre-acquisition equity account of - Prema Life   823,043 
Elimination of pre-acquisition equity account of - GGLG   310,091 
Pro Forma Combined as of September 30, 2020  $3,686,465 

 

  v) To record the following adjustments to accumulated other comprehensive income/(loss):

 

Balance before pro forma adjustments  $(16,316)
Elimination of pre-acquisition equity account of - Prema Life   (4,695)
Elimination of pre-acquisition equity account of - GGLG   12,291 
Pro Forma Combined as of September 30, 2020  $(8,720)

 

(E) To record the following adjustments to revenue:

 

Balance before pro forma adjustments  $1,814,610 
Effects of intercompany eliminations - GGLG   (45,403)
Pro Forma Combined as of September 30, 2020  $1,769,207 

 

(F) To record the following adjustments to operating expenses:

 

Balance before pro forma adjustments  $(1,797,529)
Effects of intercompany eliminations – Prema LIfe   45,403 
Pro Forma Combined as of September 30, 2020  $(1,752,126)

 

Note 3. Pro Forma Adjustments

 

The following pro forma adjustments are included in the unaudited pro forma condensed combined balance sheet and combined statement of operations for the three months period ended December 31, 2020:

 

(A) To record the following adjustments to revenue:

 

Balance before pro forma adjustments  $476,541 
Effects of intercompany eliminations - GGLG   (18,537)
Pro Forma Combined as of December 31, 2020  $458,004 

 

(B) To record the following adjustments to operating expenses:

 

Balance before pro forma adjustments  $(550,631)
Effects of intercompany eliminations – Prema Life   18,537 
Pro Forma Combined as of December 31, 2020  $(532,094)

 

6